Scott M Coiante Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Scott M Coiante.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Scott M Coiante. Scott M Coiante is Chief Financial Officer in AGILE THERAPEUTICS INC ($AGRX) and SVP, Chief Financial Officer in Aprea Therapeutics, Inc. ($APRE).
Latest Insider Trading Transactions of Scott M Coiante
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 01 2021 | APRE | Aprea Therapeutics ... | Coiante Scott M | SVP, Chief Financia ... | Option Exercise | A | 6.00 | 143,000 | 858,000 | 143,000 | |
Mar 01 2021 | APRE | Aprea Therapeutics ... | Coiante Scott M | SVP, Chief Financia ... | Grant | A | 0.00 | 63,500 | 0 | 99,000 | 35.5 K to 99 K (+178.87 %) |
Mar 01 2021 | APRE | Aprea Therapeutics ... | Coiante Scott M | SVP, Chief Financia ... | Grant | A | 0.00 | 33,000 | 0 | 35,500 | 2.5 K to 35.5 K (+1,320.00 %) |
Mar 26 2020 | APRE | Aprea Therapeutics ... | Coiante Scott M | SVP, Chief Financia ... | Option Exercise | A | 35.50 | 55,000 | 1,952,500 | 55,000 | |
Oct 07 2019 | APRE | Aprea Therapeutics ... | Coiante Scott M | SVP, Chief Financia ... | Option Exercise | A | 15.00 | 150,824 | 2,262,360 | 150,824 | |
Oct 07 2019 | APRE | Aprea Therapeutics ... | Coiante Scott M | SVP, Chief Financia ... | Option Exercise | A | 15.00 | 150,824 | 2,262,360 | 150,824 | |
Oct 07 2019 | APRE | Aprea Therapeutics ... | Coiante Scott M | SVP, Chief Financia ... | Buy | P | 15.00 | 2,500 | 37,500 | 2,500 | 0 to 2.5 K |
Oct 07 2019 | APRE | Aprea Therapeutics ... | Coiante Scott M | SVP, Chief Financia ... | Buy | P | 15.00 | 2,500 | 37,500 | 2,500 | 0 to 2.5 K |
Jan 31 2019 | AGRX | AGILE THERAPEUTICS ... | Coiante Scott M | Chief Financial Off ... | Option Exercise | A | 2.50 | 38,500 | 96,250 | 38,500 | |
Jan 31 2019 | AGRX | AGILE THERAPEUTICS ... | Coiante Scott M | Chief Financial Off ... | Option Exercise | A | 0.84 | 172,600 | 144,984 | 172,600 | |
Jan 28 2019 | AGRX | AGILE THERAPEUTICS ... | Coiante Scott M | Chief Financial Off ... | Option Exercise | M | 0.00 | 17,500 | 0 | 0 | |
Jan 28 2019 | AGRX | AGILE THERAPEUTICS ... | Coiante Scott M | Chief Financial Off ... | Option Exercise | M | 0.00 | 16,070 | 0 | 17,500 | |
Jan 28 2019 | AGRX | AGILE THERAPEUTICS ... | Coiante Scott M | Chief Financial Off ... | Buy | M | 0.00 | 17,500 | 0 | 48,256 | 30.8 K to 48.3 K (+56.90 %) |
Jan 28 2019 | AGRX | AGILE THERAPEUTICS ... | Coiante Scott M | Chief Financial Off ... | Buy | M | 0.00 | 16,070 | 0 | 30,756 | 14.7 K to 30.8 K (+109.42 %) |
Jun 21 2018 | AGRX | AGILE THERAPEUTICS ... | Coiante Scott M | Chief Financial Off ... | Option Exercise | A | 0.58 | 150,000 | 87,000 | 150,000 | |
Jan 26 2018 | AGRX | AGILE THERAPEUTICS ... | Coiante Scott M | Chief Financial Off ... | Option Exercise | M | 0.00 | 17,500 | 0 | 33,570 | |
Jan 26 2018 | AGRX | AGILE THERAPEUTICS ... | Coiante Scott M | Chief Financial Off ... | Option Exercise | A | 0.00 | 16,070 | 0 | 51,070 | |
Jan 26 2018 | AGRX | AGILE THERAPEUTICS ... | Coiante Scott M | Chief Financial Off ... | Option Exercise | A | 3.46 | 107,000 | 370,220 | 107,000 | |
Jan 26 2018 | AGRX | AGILE THERAPEUTICS ... | Coiante Scott M | Chief Financial Off ... | Payment of Exercise | F | 3.32 | 6,753 | 22,420 | 14,686 | 21.4 K to 14.7 K (-31.50 %) |
Jan 26 2018 | AGRX | AGILE THERAPEUTICS ... | Coiante Scott M | Chief Financial Off ... | Buy | M | 0.00 | 17,500 | 0 | 21,439 | 3.9 K to 21.4 K (+444.28 %) |
Jan 27 2017 | AGRX | AGILE THERAPEUTICS ... | Coiante Scott M | Chief Financial Off ... | Option Exercise | A | 0.00 | 35,000 | 0 | 35,000 | |
Jan 27 2017 | AGRX | AGILE THERAPEUTICS ... | Coiante Scott M | Chief Financial Off ... | Option Exercise | A | 2.26 | 100,000 | 226,000 | 100,000 | |
Feb 10 2016 | AGRX | AGILE THERAPEUTICS ... | Coiante Scott M | Chief Financial Off ... | Option Exercise | A | 5.93 | 95,000 | 563,350 | 95,000 | |
Feb 23 2015 | AGRX | AGILE THERAPEUTICS ... | Coiante Scott M | Chief Financial Off ... | Option Exercise | A | 10.75 | 37,500 | 403,125 | 37,500 | |
Feb 23 2015 | AGRX | AGILE THERAPEUTICS ... | Coiante Scott M | Chief Financial Off ... | Option Exercise | A | 9.45 | 37,500 | 354,375 | 37,500 | |
Jun 26 2014 | AGRX | AGILE THERAPEUTICS ... | Coiante Scott M | Chief Financial Off ... | Option Exercise | A | 10.75 | 118,000 | 1,268,500 | 118,000 |
Page: 1